Argyrophilic grain disease (AGD) is a common fourrepeat tauopathy in elderly people. While dementia is a major clinical picture of AGD, recent studies support the possibility that AGD may be a pathological base in some patients with mild cognitive impairment, late-onset psychosis, bipolar disorder and depression. AGD often coexists with various other degenerative changes. The frequency of AGD in progressive supranuclear palsy (PSP) cases was reported to range from 18.8% to 80%. The frequency of AGD in corticobasal degeneration (CBD) cases tends to be higher than that in PSP cases, ranging from 41.2% to 100%. Conversely, in our previous study of the frequencies of mild PSP and CBD pathologies in AGD cases, five of 20 AGD cases (25%) had a few Gallyaspositive tufted astrocytes, six cases (30%) had a few granular/fuzzy astrocytes, and one case (5.0%) had a few Gallyas-positive astrocytic plaques in the putamen, caudate nucleus and/or superior frontal gyrus. Both Gallyaspositive tufted astrocytes and Gallyas-negative tau-positive granular/fuzzy astrocytes preferentially developed in the putamen, caudate nucleus and superior frontal cortex in AGD cases, being consistent with the predilection sites of Gallyas-positive tufted astrocytes in PSP cases. Further, in AGD cases, the quantities of Gallyas-positive tufted astrocytes, overall tau-positive astrocytes, and tau-positive neurons in the subcortical nuclei and superior frontal cortex were significantly correlated with Saito AGD stage, respectively. The frequency of AGD in AD cases was reported to reach up to 25% when using four-repeat tau immunohistochemistry.
INTRODUCTION
Argyrophilic grains, pathological hallmarks of argyrophilic grain disease (AGD), are comma or spindle-shaped lesions of four-repeat (4R) tau protein that are selectively accumulated in neuronal processes. The first reported clinical feature in AGD cases is dementia. 1 Subsequently, it was also reported that AGD may be associated with several psychiatric conditions in late life. [2] [3] [4] Pathologically, it is known that AGD often coexists with other neurodegenerative diseases. However, whether the comorbidity reflects some pathogenic linkage and affects clinical presentations in other diseases remains unclear.
In this paper, we first summarize clinical and pathological features in AGD, as well as related issues that may be important when considering the significance of the comorbidity of AGD and other degenerative diseases. Then, we overview pathological findings regarding the coexistence of AGD with progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), Alzheimer's disease (AD), Lewy body disease (LBD), and transactivation response DNA protein 43 (TDP-43) proteinopathies.
EPIDEMIOLOGICAL ASPECTS OF AGD
AGD is the second most common neurodegenerative disease causing dementia in elderly patients. Braak reported that, in 2661 serial autopsy cases (age at death: 25-96 years), AGD was found in 125 cases (5%). 5 The age at death in AGD cases was 51-96 years. The frequency of AGD increased with age from 5% or under in cases 50-60 years old to over 10% in cases 70 years or older. 5 The frequency of AGD in the oldest cases (100 years or over) may increase extremely up to 31.3%. 6 
PATHOLOGICAL FEATURES IN AGD Argyrophilic grains
Argyrophilic grains are spindle-or comma-shaped Gallyaspositive, 4R tau-positive lesions that are located in neuronal dendrites and axons ( Fig. 1g ,h,m-o). 1, 7 In the process of formation of argyrophilic grains, the lesions may be first stained with AT8, followed by anti-4R tau antibodies, and Gallyas method, and some researchers call Gallyas-negative tau-positive structures with morphological features of argyrophilic grains "pregrains." 8 Therefore, the frequency of AGD may be affected by staining methods applied. In our experience, it is not always easy to distinguish argyrophilic grains from cross sections of dystrophic neurites of AD pathology, especially when evaluating a small number of argyrophilic grains in AD cases using only AT8 or RD4 immunohistochemistry. On the other hand, although the Gallyas method is more effective to demonstrate 4R tau-positive lesions than three-repeat (3R) taupositive lesions, 9 it does not always successfully disclose 4R tau pathology, even in cases having numerous lesions. 10 
Pretangles and NFTs
Pretangles have diffuse or granular tau accumulation in the cytoplasm of neurons containing few fibrillary structures, being frequently found in AGD cases. Like argyrophilic grains, pretangles in AGD cases consist of 4R tau but not 3R tau. Tau immunohistochemistry, and to a lesser extent the Gallyas method also, demonstrate pretangles. Pretangles are also found in AD cases. Therefore, it is difficult to evaluate whether neuronal tau accumulation in AGD cases coexists with AD pathology or primary age-related tauopathy (PART) 11 using AT8
immunohistochemistry. Theoretically, some NFTs as AD and PART pathology can be distinguished from pretangles of AGD pathology using a 3R tau-specific antibody (e.g. RD3). In 19 AGD cases that we examined, the Braak stage of 3R tau-positive NFTs was not significantly correlated with the Saito AGD stage. 12 Given these findings, 3R tau-positive NFTs may be independent of the pathophysiology of AGD.
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Coiled bodies and ballooned neurons
These lesions are frequently found in AGD cases, but are not AGD-specific. Coiled bodies are lash-, comma-or fishhook-like Gallyas-positive, tau-positive inclusions in the cytoplasm of oligodendrocytes (Fig. 1i-k) . AGD cases consistently have coiled bodies, 13 suggesting that coiled bodies may occur in a very early phase in the formation of argyrophilic grains. However, the lesions are also found in cases of PSP, CBD, Pick's disease and AD. Ballooned neurons are stained with antibodies to phosphorylated tau, phosphorylated neurofilament and αB-crystallin (Fig. 1l) . In AGD cases, ballooned neurons are frequently found in the amygdala and entorhinal cortex. 14, 15 Ballooned neurons also develop in CBD cases; however, they are frequently found in not only limbic regions but also the fronto-parietal cortex, differing from AGD in anatomical distribution.
CLINICAL ASPECTS OF AGD
Several neurological and psychiatric conditions were reported to be potentially associated with AGD. However, except for dementia, the onset mechanism of psychiatric conditions (e.g. psychosis, bipolar disorder and depression) and the degree of contribution of AGD to that onset remain unclear.
Dementia and mild cognitive impairment
The development of dementia is closely associated with the progression of AGD in the brain. 16, 17 The most frequent initial symptom of AGD cases with dementia is memory impairment, followed by irritability and agitation. 18 Some AGD cases can exhibit dementia with prominent anxiety, depressive mood, aggression, agitation and irritability ( Fig. 1a-o) . 19, 20 Dementia characterized by disinhibited behaviors was reported to be observed in cases having extensive AGD. 21 Disinhibited behaviors without dementia are also rarely seen in cases having AGD ( Fig. 2a-l) . 22 To our knowledge, there is no reported AGD case that showed semantic memory impairment. However, although probably rare, in our personal series, there is an AGD case that exhibited face recognition impairment as an initial symptom ( Fig. 2a-l) . AGD was also reported to be one of the potential pathological bases in patients with mild cognitive impairment (MCI). [23] [24] [25] [26] preserved people older than 40 years of age (mean onset age: 63.3 AE 12.9 years, mean age at death: 75.1 AE 7.5 years). 2 Of 23 LOSD cases, five (21.7%) had AGD (Saito stages I-II. Fig. 1m-o) . Other degenerative diseases were LBD in six cases (26.1%), CBD in one case (4.3%), and moderate NFTs (Braak stages III-IV) in two cases (8.7%). The AGD stage in all LOSD cases was significantly higher than that in 71 age-matched control cases. Of 11 LOSD cases with onset at ≥65 years of age (median age at death, 79 years), four cases (36.4%) had AGD. The frequency of AGD was significantly higher in LOSD cases with onset at ≥65 years of age than in 36 agematched normal control cases. LOSD patients with onset at ≥65 years of age had a significantly increased risk of having AGD (odds ratio, 6.29; 95% CI, 1.14-34.6) compared to age-matched normal controls. Because the severity of AGD observed in LOSD cases was mild to moderate (Saito stage I or II) but not severe (Saito stage III), the prediction of underlying AGD by structural imaging may be difficult. It is noteworthy that the mean age at onset (41.8 AE 12.6 years) in these bipolar disorder cases having AGD was relatively high. For example, it has been reported that the mean age at onset in patients with bipolar disorder ranged from 17 to 27 years, and the most common age at onset is the teenage years. 28 In contrast, in 10 of 11 bipolar disorder cases with AGD for which onset age was available, the age at onset was the 20s (22 and 28 years) in two cases, 30s (33, 34 , and 38 years) in three cases, 45 years in one case, and 50s (50, 56, 56 and 56 years) in four cases. These findings suggest that clinically diagnosed bipolar disorder cases may have pathologically heterogeneous bases, and that AGD might be associated with late-onset bipolar disorder in middle age or later.
Bipolar disorder
Aggravation of post-stroke depression
Yoshida et al. 4 pathologically examined 24 autopsy cases of post-stroke depression, and demonstrated that 11 poststroke depression suicide cases had AGD (n = 5), AGD + PSP (n = 1), PSP (n = 1) and Lewy body disease (n = 1). In contrast, of the remaining 13 non-suicide post-stroke depression cases, only two cases had AGD. 
Tufted astrocytes and granular/fuzzy astrocytes in AGD cases
Although the sample size was small, several previous studies demonstrated that some AGD cases had a small number of tufted astrocytes in the basal ganglia and brain stem nuclei. 31 Gallyas-negative tau-positive bush-like astrocytes in the limbic region were also reported. 32 Recently, a classification of the major tau-positive astrocytic lesions in degenerative diseases has been proposed. 33 In the consensus paper, it was noted that disease-specific tau-positive astrocytic lesions are tufted astrocytes in PSP, astrocytic plaques in CBD, globular astroglial inclusions in globular glial tauopathy, and ramified astrocytes in Pick's disease. At age 71, she initially showed auditory hallucination and persecutory delusion. She said "primary school children are speaking ill of me." She was admitted to a psychiatric hospital. Thereafter, visual hallucination also occurred. She said "a cat with big eyes is sitting" and "a row or line of police men are standing." Electroencephalography did not demonstrate slow waves, and delirium was absent. At age 75, auditory hallucination continued: she said "a strange woman tells me to kill myself." Parkinsonism was absent. At age 76, she attempted a suicide by hanging. She died of ureteral cancer with a disease duration of 6 years. Dementia was absent throughout the course. The final psychiatric diagnosis was senile delusional state. Pathologically, the brain weighed 1070 g. Moderate AGD with Saito stage II and minimal NFTs with Braak stage II were found. Moderate Aβ deposits with Thal phase 3 were present in the neocortex and basal ganglia. Gallyas-negative tau-positive astrocytes were found in the putamen and oculomotor nucleus. On the other hand, thorn-shaped astrocytes and granular/ fuzzy astrocytes are defined as age-related tau astrogliopathy. It was noted that histological features of bush-like astrocytes are consistent with those in granular/ fuzzy astrocytes. 34 No AGD-specific tau-positive astrocytic lesions were noted. Although tufted astrocytes are pathological hallmarks of PSP, we recently reported that some AGD cases had a small number of Gallyas-positive tau-positive tufted astrocytes (Figs 2j,3e-h,m-p) , 12 even when AGD cases did not have sufficient NFTs to fulfill the pathological criteria of PSP. 34 In our study, we explored astrocytic lesions in the superior frontal cortex, caudate nucleus, putamen, globus pallidus, subthalamic nucleus, substantia nigra, oculomotor nucleus, pontine nucleus, inferior olivary nucleus and cerebellar dentate nucleus in 20 AGD cases using Gallyas method and AT8 immunohistochemistry. In our original report, 12 the term "Gallyas-negative tau-positive tufted astrocyte-like astrocytic inclusions" was used to refer to "granular/fuzzy astrocytes" proposed later by Kovacs et al. 33 Indeed, we confirmed that all of the Gallyas-negative tau-positive tufted astrocyte-like astrocytic inclusions in AGD cases examined previously 12 were actually granular/fuzzy astrocytes in re-evaluation. Therefore, we used the term granular/fuzzy astrocytes in this paper. Figure 4 shows the frequency of tau-positive astrocytic lesions in 20 AGD cases. 12 Of 20 AGD cases, five (25%) had both Gallyas-positive tau-positive tufted astrocytes and Gallyas-negative tau-positive granular/fuzzy astrocytes. Six cases (30%) had Gallyas-negative taupositive granular/fuzzy astrocytes but lacked Gallyaspositive tau-positive tufted astrocytes. Only one AGD case (5.0%) had a very small number of Gallyas-positive tau-positive astrocytic plaques. In the remaining eight cases (40%), no tau-positive astrocytic lesions were found in any region examined. Gallyas-positive tufted astrocytes in AGD cases cannot be morphologically distinguished from tufted astrocytes observed in PSP cases.
12 Granular/fuzzy astrocytes were observed in both AGD cases having Gallyas-positive tufted astrocytes (Fig. 3a-d ,i-l) and AGD cases lacking them ( Fig. 3q-t) . In our experience, it is not always easy to demarcate the boundary between granular/fuzzy astrocytes and tufted astrocytes on AT8-immunostained sections in AGD cases having Gallyas-positive tufted astrocytes. 12 However, tau-positive granules in granular/ fuzzy astrocytes in AGD cases without Gallyas-positive tufted astrocytes (Fig. 3q-t) tended to be more fine than those in AGD cases with Gallyas-positive tufted astrocytes ( Fig. 3a-d,i-l ). 12 Figure 5 shows the distributions of Gallyas-positive tau-positive tufted astrocytes (red bars) and Gallyas-negative tau-positive granular/fuzzy astrocytes (purple bars) in AGD cases. 12 Both Gallyas-positive tufted astrocytes and Gallyas-negative tau-positive granular/fuzzy astrocytes preferentially developed in the putamen, caudate nucleus and superior frontal cortex in AGD 34 The subcortical nuclei and superior frontal gyrus in 20 AGD cases were examined. Five (25%) had both Gallyas-positive AT8-positive tufted astrocytes and Gallyas-negative AT8-positive granular/fuzzy astrocytes. Six cases (30%) had Gallyas-negative AT8-positive granular/ fuzzy astrocytes but lacked Gallyas-positive AT8-positive tufted astrocytes. One AGD case (5.0%) had a very small number of Gallyaspositive AT8-positive astrocytic plaques. The remaining eight cases (40%) lacked any AT8-positive astrocytic lesions. A graph produced using the data from Ikeda et al.
cases. 12 Further, the predilection sites of these astrocytic lesions in AGD cases were consistent with those of Gallyas-positive tufted astrocytes observed in PSP cases (green bars).
12
Double staining by AT8 immunohistochemistry and the Gallyas method clearly demonstrated the positional relationship between Gallyas-positive tau-positive astrocytes and Gallyas-negative tau-positive granular/fuzzy astrocytes in AGD cases (Fig. 6a-d) . 12 Small numbers of fine Gallyas-positive glial thread-like structures were often observed in the distal portion of some tau-positive granular/fuzzy astrocytes ( Fig. 6a-d) . 12 In PSP cases without AGD also, granular/fuzzy astrocytes with and without a varying quantity of Gallyas-positive glial threads, in addition to Gallyas-positive tufted astrocytes, were found (Fig. 6e,f ) . 12 Whether at least some granular/fuzzy astrocytes can evolve into Gallyas-positive tufted astrocytes should be explored.
Relationship between tau-positive astrocytic inclusions and the severity of AGD Figure 7 shows the relationship between Saito AGD stage and the quantity of tau-positive astrocytic lesions in 19 AGD cases. 12 The number of AT8-positive astrocytic inclusions (including Gallyas-negative AT8-positive granular/fuzzy astrocytes and Gallyas-positive tufted astrocytes) in the caudate nucleus, oculomotor nucleus and inferior olivary nucleus significantly increased with Saito AGD stage. Further, the quantity of AT8-positive astrocytic inclusions was significantly correlated with the progression of AGD in the caudate nucleus, putamen and subthalamic nucleus. 12 Figure 8 shows a similar trend between AGD stage and the quantity of Gallyas-positive tufted astrocytes in the same 19 AGD cases.
Relationship between neuronal tau accumulation in subcortical nuclei and severity of AGD Like tau-positive astrocytes, several previous studies demonstrated that some AGD cases had neuronal tau accumulation in the subcortical nuclei. 29, 31, [35] [36] [37] [38] Figure 9 shows the relationship between the Saito AGD stage and the quantity of tau-positive neurons in the subcortical nuclei in 19 AGD cases previously reported. 12 The number of tau-positive neurons in the subcortical nuclei increased with the progression of AGD. Further, the AGD stage was significantly correlated with the quantity of tau-positive neurons in the caudate nucleus, putamen, globus pallidus, subthalamic nucleus and substantia nigra. In contrast to the high frequency of AGD in CBD cases, astrocytic plaques in AGD cases may be very rare. In our previous study, only one of 20 AGD cases (5.0%) had a few astrocytic plaques in the superior frontal gyrus, caudate nucleus, putamen and globus pallidus (Fig. 4) . 12 It is noteworthy that, in our AGD cases, the frequency of tufted astrocytes was far higher than that of astrocytic plaques. 12 This finding also led us to consider that the pathophysiological relationship between AGD and PSP differs from that between AGD and CBD. 12 Conversely, it was reported that the frequency of AGD in AD cases increased up to 25.5% when an anti-4R tau antibody was used. 42 In our 19 AGD cases examined previously, nine cases (60.0%) had various degrees of Aβ deposition. 12 The degree of Aβ deposits was Thal phase 1 in one case (5.3%), phase 2 in one (5.3%), phase 3 in four (21.1%), phase 4 in one (5.3%) and phase 5 in two (10.5%). However, in our series, even when Aβ deposits were extensively distributed, no AGD case had high-level AD pathology according to the pathological criteria of AD because the distribution of neuritic changes was frequently limited in the limbic regions. 43 Thal et al. 44 reported that the coexistence of AGD may reduce the threshold at which cases having moderate AD pathology clinically develop dementia. On the other hand, Like tau-positive astrocytes, the quantity of Gallyas-positive tufted astrocytes tends to be sequentially increased with the progression of AGD, and significant difference between AGD stages was found in the frontal cortex. Graphs produced using the data in our previous study.
PATHOLOGICAL RELATIONSHIP BETWEEN AGD AND CBD PATHOLOGY
PATHOLOGICAL RELATIONSHIP BETWEEN AGD AND AD
whether the coexistence of AGD can contribute to the development of psychiatric symptoms in AD cases is unclear. In our personal series, there is an AD case with AGD that initially showed schizophrenia-like observational delusion ( Fig. 10a-h) . The relationship between psychotic symptoms in AD and AGD should be investigated in the future. 58 Whether the discrepancy between the frequencies in the two case series can be explained by the difference of the age at death or sampling bias is unclear. The available data regarding the frequency of AGD in frontotemporal lobar degeneration (FTLD) with TDP-43-positive inclusions (FTLD-TDP) are very limited. In our previous study in which 20 FTLD-TDP cases (mean age at death: 62.6 AE 9.6 years) were examined, the TDP-43 histological subtype was type A in four cases, type B in five cases, and type C in 11 cases, and no case had AGD. 59 Even if the coexistence of AGD and primary TDP-43 proteinopathies is an incidental phenomenon, neuronal and astrocytic tau accumulation in the subcortical nuclei and frontal cortex can be found in ALS cases having AGD (Fig. 11a-l) . Further, when massive tau pathology due to AGD coexists, it can cause evident tissue degeneration. In our ALS case bearing severe AGD (Saito stage III) reported previously, abundant tau-positive lesions, but almost no ubiquitin-positive inclusions, were found in the temporal cortex, and the region showed severe atrophy on MRI. 60 Further, this case also had mild PSP-like tau pathology, that is, tau-positive neurons and granular/fuzzy astrocytes in the caudate nucleus, globus pallidus, thalamus, subthalamic nucleus, substantia nigra and/or superior frontal gyrus, 60 although parkinsonism was not noted in life.
PATHOLOGICAL RELATIONSHIP BETWEEN AGD AND LBD
CONCLUSIONS
Because AGD increases in frequency with age, it is commonly found in elderly people. AGD often coexists with various degenerative diseases. Although whether the comorbidity of AGD and other degenerative changes reflects a certain pathogenic relationship remains unclear, clinicians should consider the possibility that coexisting AGD might affect clinical and radiological features in other degenerative diseases. In addition, considering that PSP-like subcortical tau pathologies are often found in AGD cases, whether coexisting AGD has an impact on not only cognitive function but also motor function should be explored. 
